Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003255700 | SCV003947991 | uncertain significance | Inborn genetic diseases | 2023-05-17 | criteria provided, single submitter | clinical testing | The c.9373A>G (p.K3125E) alteration is located in exon 9 (coding exon 9) of the FAT4 gene. This alteration results from a A to G substitution at nucleotide position 9373, causing the lysine (K) at amino acid position 3125 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005029958 | SCV005657508 | uncertain significance | Van Maldergem syndrome 2; Hennekam lymphangiectasia-lymphedema syndrome 2 | 2024-04-10 | criteria provided, single submitter | clinical testing |